A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT06767748 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

620

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: GZR4
DRUG: insulin degludec

Sponsor

Gan & Lee Pharmaceuticals.